Pericarditis
Showing 1 - 25 of 1,383
MYocarditis and/or Pericarditis Following mRNA COVID-19
Recruiting
- Myocarditis
- +3 more
- Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire
- Baseline Quality of Life questionnaire
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Oct 24, 2023
Risk Factors of Myocarditis and Pericarditis After Moderna
Active, not recruiting
- Myocarditis, Pericarditis
- mRNA-1273
-
Aarhus, Denmark
- +4 more
Oct 31, 2023
Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)
Not yet recruiting
- Pericarditis Idiopathic Recurrent
-
Athens, Attiki, Greece"Hippokration" General Hospital of Athens
Feb 20, 2023
Idiopathic Recurrent Pericarditis Trial in Saint Petersburg (RPH-104)
Active, not recruiting
- Idiopathic Recurrent Pericarditis
- RPH-104
-
Saint Petersburg, Russian FederationNational medical research center named after V. A. Almazov
Dec 21, 2022
Covid-19 Vaccine Associated Myocarditis and Pericarditis in
Enrolling by invitation
- Myocarditis
- no intervention
-
Oslo, NorwayOslo University Hospital
Nov 8, 2022
18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis
Completed
- Diagnostic Self Evaluation
- 18F-FDG
- (no location specified)
Jul 11, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
ACAM2000® Myopericarditis Registry
Completed
- Myocarditis
- Pericarditis
-
San Diego, California(unnamed)
Aug 17, 2022
Recurrent Pericarditis Trial in Richmond (RPH-104, Placebo)
Not yet recruiting
- Recurrent Pericarditis
- RPH-104
- Placebo
-
Richmond, VirginiaVirginia Commonwealth University
Jun 2, 2022
Myocarditis, Cardiac Sarcoidosis, Pericarditis Trial in Bern
Enrolling by invitation
- Myocarditis
- +2 more
-
Bern, SwitzerlandDepartment of Cardiology, University Hospital Bern, Inselspital,
May 17, 2022
Myocarditis, Pericarditis Trial in Ottawa
Recruiting
- Myocarditis
- Pericarditis
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Mar 14, 2022
Pericarditis Acute Trial in Petach Tikva (Dexamethasone therapy, NSAID therapy)
Recruiting
- Pericarditis Acute
- Dexamethasone therapy
- NSAID therapy
-
Petach Tikva, IsraelRabin Medical Center
Sep 30, 2021
Recurrent Pericarditis Trial in United States
Recruiting
- Recurrent Pericarditis
-
Anchorage, Alaska
- +16 more
Jun 9, 2022
Pericarditis: Auto-Inflammation in Recurrent Disease
Recruiting
- Idiopathic Recurrent Pericarditis
-
London, United Kingdom
- +1 more
Aug 11, 2021
CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Recruiting
- Myocarditis
- +5 more
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Aug 19, 2022
Atrial Fibrillation, Catheter Ablation, Pericarditis Trial in Indianapolis (Colchicine)
Recruiting
- Atrial Fibrillation
- +2 more
-
Indianapolis, IndianaAscension St Vincent Hospital
May 27, 2021
Myocarditis Trial in Boston, Salt Lake City (Cardiac Imaging)
Recruiting
- Myocarditis
- Cardiac Imaging
-
New Orleans, Louisiana
- +3 more
Jan 20, 2023
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022
Acute Pericarditis Trial in Richmond (Anakinra, Placebo)
Terminated
- Acute Pericarditis
- Anakinra
- Placebo
-
Richmond, VirginiaVirginia Commonwealth University
Feb 5, 2021
Liver Parenchyma Using Parametric T1 and T2 Magnetic Resonance
Completed
- Cardiomyopathy, Congestive
- +3 more
- T1 and T2 relaxometry of the liver parenchyma
- (no location specified)
Nov 4, 2020
Suspicion of Cardiovascular Events on Immunecheckpoint
Recruiting
- Cancer
- +3 more
- No intervention for research purposes only
-
Paris, FranceIntitut Mutualiste Montsouris
Mar 23, 2023
GENE SEQUENCING AS A STRATEGY FOR IDENTIFYING GENETIC FACTORS
Recruiting
- Covid-19 Vaccination Serious Adverse Events
-
Rio De Janeiro, BrazilUnidade de Ensaios Clínicos para Imunobiológicos (UECI)
Nov 23, 2022